COVID-19 Vaccine Provider Weekly Updates

Stay Safe MN logo

COVID-19 Vaccine Provider Weekly Updates

View this as a webpage

Minnesota Department of Health

September 15, 2022


Pause on Moderna bivalent booster (18+) ordering

We recently heard from CDC that Moderna bivalent booster (18+) allocations will arrive later than initially anticipated. As a result, we have temporarily removed Moderna bivalent boosters from ordering in MIIC. We will notify providers when Moderna bivalent boosters will be available for ordering again and ask providers to place their orders at that time. We suggest placing an order for Pfizer bivalent vaccine (12+) with minimum shipment quantity of 300 doses in MIIC if you would like to receive vaccine within the next 2 weeks. Please contact with questions.

Find COVID-19 vaccine locations update

The Pfizer bivalent booster (12+) and Moderna bivalent booster (18+) has been added to the Find COVID-19 vaccine locations tool. We strongly encourage you to use the provider site intake form to add and modify your vaccination sites when you are ready to administer bivalent booster vaccine formulations. Sites are also able to differentiate between offering primary series and booster presentations in the 12+ age group. Options will include specific age groups you serve, based on your provider type.

Questions on the Find COVID-19 vaccine locations tool can be directed to Julie Viken at and Anthony Jumelles at

Reporting monovalent booster errors to VAERS

With the monovalent COVID-19 vaccine no longer being authorized as a booster dose for people age 12 and older effective August 31, any monovalent mRNA COVID-19 vaccine booster administration to people 12 and older must be reported to CDC’s Vaccine Adverse Event Reporting System (VAERS).

Co-administration of COVID-19 vaccines and other vaccines

With the flu season fast approaching, remember that CDC’s Interim Clinical Considerations for Use of COVID-19 Vaccines  supports administering COVID-19 vaccine with other vaccines, including flu, on the same day. When deciding whether to administer other vaccine(s) with COVID-19 vaccine, vaccination providers should consider whether the patient is behind, or at risk of becoming behind, on recommended vaccines; their risk of the vaccine-preventable disease; and the reactogenicity profile of the vaccines. Administer COVID-19 vaccines and vaccines that may be more likely to cause a local reaction in different limbs, if possible. For more information, please review best practices for administering multiple injections at CDC Administer the Vaccine(s).

Pfizer and Moderna bivalent vaccine trainings

Pfizer and Moderna COVID-19 vaccine trainings now include information on bivalent vaccine presentations. More information including links to attend educational sessions can be found at Pfizer: Medical Updates & Immunization Site Training for All Healthcare Providers led by Pfizer Vaccines US Medical Affairs and National Educational Webinars: "Moderna COVID-19 Vaccine, Bivalent".  Moderna is also offering daily interactive office hours found at Regional Medical Affairs Office Hours: "Moderna COVID-19 Vaccine, Bivalent".

Novavax COVID-19 vaccine office hours

Novavax is hosting office hours to give details on the vaccine and answer questions. Providers are encouraged to have all staff involved in Novavax vaccine administration and handling attend these trainings. Register at Meeting Registration: Novavax Office Hours

Find previous bulletins at COVID-19 Vaccine Provider Updates.